Device Information


The Resonator™ device uses electro-magnetic stimulation in order to relieve symptoms of a disorder or disease.


 

Please Download the latest version of Adobe Flash Player.

 

ABOUT US

Our Team

Participate in our research
News Releases

Terms & Conditions of Use

 
 
 
 
   
   


Device Details

The Resonator™ device is a device that is controlled by a computer that is connected to a magnetic therapy driver enclosure that contains a signal generator in cooperative operation with an attenuator circuit to produce a magnetic field. (see figure 1., above)

A signal generator provides the “signal in” while the attenuator circuit  is prepared for a helmholtz coil that is 7 feet in diameter. The resonator system is designed to create a homogeneous, isotropic magnetic field in the picoTesla (pT) range, most specifically from 1 pT to 99 pT and a frequency range from .01 Hz to 50.0 Hz (specifically for this trial); and utilizing an electrical current thereby producing a changing magnetic field in between the Helmholtz coil system. The patient may be sitting or in a supine position between the coils. The term resonance used with respect to this device refers specifically to “amplitude” resonance. Field polarity changes are to be used for the system under discussion, and limited to .1 Hz to 50.0 Hz.


Signal Generator and Attenuation Circuit Board

The board uses an Atmel AT32UC3A0512 µprocessor with an Ethernet port, USB, and SPI interfaces. The SPI interface is primarily used to communicate with the Little Nik Controller-Attenuator. The frequency generator, AD9832, the DAC’s, AD5680, and the relay drivers, MAX4820, are parts on the board and all use the SPI port addresses as outlined in the specifications document. There is a computer running the user interface software (GUI) that is connected to the microprocessor via an Ethernet interface.

The signal generator produces the precise amplitude for the desired magnetic field. The generator is capable of 1 millivolt to 4 volts amplitude generation into a 1000-ohm load termination. The attenuator uses the signal produced by the generator to drive the coils of the resonator.

The attenuation circuit uses the signal produced by the generator to drive the Helmholtz coils. The circuitry is custom designed to provide impedance matching to the generator and selectable attenuation of the signal. The attenuation range is from 10 milli gauss to 1 nano gauss by combining the generator range and the attenuator selection ranges. Circuitry within the unit provides for continuity verification after assembly of the system to confirm a complete circuit for the signal generator.


Helmholtz Coils

The magnetic fields are produced by simplified Helmholtz coils. The coils are 7 feet in diameter with a separation of 3 ½ feet. The coils’ uniformity, density, wire gauge, current and voltage were determined by the requirements to produce the required magnetic fields as defined by the foregoing signal parameter’s intended use.

The system to be used in this study includes a fiberglass platform with steps for the subject to walk up and mount the platform. Handrails serve to provide stability as the subject walks up the steps to the platform. The coils are fiberglass rings with copper wire wound around an end groove. Because of the size of the coils, a support connects one coil to the other coil, to provide stability, and the coils are mounted onto the platform through coil supports. No ferrous metals are used in the construction of the Resonator™ device.

 
 

4700 140th Ave. N., Suite 101 • Clearwater, FL 33762 • 727-474-3722

HOME | CONTACT US

 
 

The Resonator™ device is an Investigational Device limited by Federal (or United States)
law to investigational use. The Resonator™ device is not for sale, nor is the Magneceutical®
Therapy generally available outside of Investigational Review Board (IRB) approved clinical studies.

 
 

Pico-Tesla Magnetic Therapies are holding clinical trials for Parkinson’s patients. They are testing to see if the new Resonator® device, using pulsed magnetic field therapy, is successful in improving the quality of life for people living with Parkinson’s disease. Those who qualify for these clinical trials will be compensated.

Currently, these clinical trials are being held in Novi, Michigan and Clearwater, Florida. All locations are in close proximity to major cities in each state. Patients interested in participating can contact Pico-Tesla for more information.